Literature DB >> 30070256

Urgent need for pragmatic trial platforms in severe asthma.

Charles Pilette1, Chris Brightling2, Denis Lacombe3, Guy Brusselle4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30070256     DOI： 10.1016/S2213-2600(18)30291-1

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  5 in total

Review 1.  Dupilumab and tezepelumab in severe refractory asthma: new opportunities.

Authors:  Beatrice Ragnoli; Jaymin Morjaria; Patrizia Pignatti; Paolo Montuschi; Mariangela Barbieri; Lucrezia Mondini; Luca Ruggero; Liliana Trotta; Mario Malerba
Journal:  Ther Adv Chronic Dis       Date:  2022-05-25       Impact factor: 4.970

Review 2.  Severe Asthma-Perspectives From Adult and Pediatric Pulmonology.

Authors:  Louise Fleming; Liam Heaney
Journal:  Front Pediatr       Date:  2019-10-09       Impact factor: 3.418

3.  First analysis of the Severe Paediatric Asthma Collaborative in Europe registry.

Authors:  Norrice M Liu; Karin C L Carlsen; Steve Cunningham; Grazia Fenu; Louise J Fleming; Monika Gappa; Bülent Karadag; Fabio Midulla; Laura Petrarca; Marielle W H Pijnenburg; Tonje Reier-Nilsen; Niels W Rutjes; Franca Rusconi; Jonathan Grigg
Journal:  ERJ Open Res       Date:  2020-11-02

Review 4.  Asthma and Tobacco Smoking.

Authors:  Vanesa Bellou; Athena Gogali; Konstantinos Kostikas
Journal:  J Pers Med       Date:  2022-07-27

Review 5.  T cells in severe childhood asthma.

Authors:  Alberta G A Paul; Lyndsey M Muehling; Jacob D Eccles; Judith A Woodfolk
Journal:  Clin Exp Allergy       Date:  2019-04-04       Impact factor: 5.018
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.